Last reviewed · How we verify
AV7909 Formulation 2
At a glance
| Generic name | AV7909 Formulation 2 |
|---|---|
| Sponsor | Emergent BioSolutions |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Anthrax AV7909 Liquid vs Lyophilized (PHASE1)
- Safety, Tolerability and Immunogenicity Study of AV7909 Anthrax Vaccine in Healthy Adults (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |